Old Web
English
Sign In
Acemap
>
authorDetail
>
Mirat Shah
Mirat Shah
Food and Drug Administration
Breast cancer
Internal medicine
Medicine
Placebo
Capecitabine
2
Papers
12
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
U.S. FDA Drug Approvals for Breast Cancer - A Decade in Review.
2021
Clinical Cancer Research
Shaily Arora
Preeti Narayan
Christy Osgood
Suparna Wedam
Tatiana M. Prowell
Jennifer J Gao
Mirat Shah
Danielle Krol
Sakar Wahby
Melanie Royce
Soma Ghosh
Reena Philip
Gwynn Ison
Tara Berman
Christina Brus
Erik Bloomquist
Mallorie H. Fiero
Shenghui Tang
Richard Pazdur
Amna Ibrahim
Laleh Amiri-Kordestani
Julia A. Beaver
Show All
Source
Cite
Save
Citations (0)
FDA Approval Summary: Tucatinib for the Treatment of Patients with Advanced or Metastatic HER2-Positive Breast Cancer
2020
Clinical Cancer Research
Mirat Shah
S. B. Wedam
Joyce Cheng
Mallorie H. Fiero
Huiming Xia
Fang Li
Jianghong Fan
Xinyuan Zhang
Jingyu Yu
Pengfei Song
Wei Chen
Tiffany K. Ricks
Xiao Hong Chen
Kirsten B. Goldberg
Yutao Gong
William F. Pierce
Shenghui Tang
Marc R. Theoret
Richard Pazdur
Laleh Amiri-Kordestani
Julia A. Beaver
Show All
Source
Cite
Save
Citations (12)
1